Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stock

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
European Heart Journal|August 23, 2023
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis SocietyJeanine E Roeters van Lennep, Lale S Tokgözoğlu, Lina Badimon, et al.
Microbiome|March 23, 2021
Age and sex-associated variation in the multi-site microbiome of an entire social group of free-ranging rhesus macaquesMareike C Janiak, Michael J Montague, Catalina I Villamil, et al.
American Journal of Biological Anthropology|March 6, 2024
Quantifying the relationship between bone and soft tissue measures within the rhesus macaques of Cayo SantiagoCassandra M Turcotte, Audrey M Choi, Jeffrey K Spear, et al.
American Journal of Biological Anthropology|March 6, 2024
Mechanical and morphometric approaches to body mass estimation in rhesus macaques: A test of skeletal variablesCassandra M Turcotte, Audrey M Choi, Jeffrey K Spear, et al.
The American Journal of Cardiology|December 17, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemiaJean-Charles Fruchart, Frank Sacks, Michel P Hermans, et al.
Diabetes & Vascular Disease Research|October 30, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientJean-Charles Fruchart, Frank M Sacks, Michel P Hermans, et al.
The Lancet. Diabetes & Endocrinology|October 5, 2019
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statementRobert A Hegele, Jan Borén, Henry N Ginsberg, et al.
European Heart Journal|March 27, 2018
New prospects for PCSK9 inhibition?Ulf Landmesser, M John Chapman, Jane K Stock, et al.
European Heart Journal|May 2, 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Frederick J Raal, Robert A Hegele, et al.
Atherosclerosis|May 15, 2023
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis SocietyFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
European Heart Journal|August 23, 2023
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis SocietyJeanine E Roeters van Lennep, Lale S Tokgözoğlu, Lina Badimon, et al.
Microbiome|March 23, 2021
Age and sex-associated variation in the multi-site microbiome of an entire social group of free-ranging rhesus macaquesMareike C Janiak, Michael J Montague, Catalina I Villamil, et al.
American Journal of Biological Anthropology|March 6, 2024
Quantifying the relationship between bone and soft tissue measures within the rhesus macaques of Cayo SantiagoCassandra M Turcotte, Audrey M Choi, Jeffrey K Spear, et al.
American Journal of Biological Anthropology|March 6, 2024
Mechanical and morphometric approaches to body mass estimation in rhesus macaques: A test of skeletal variablesCassandra M Turcotte, Audrey M Choi, Jeffrey K Spear, et al.
The American Journal of Cardiology|December 17, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemiaJean-Charles Fruchart, Frank Sacks, Michel P Hermans, et al.
Diabetes & Vascular Disease Research|October 30, 2008
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientJean-Charles Fruchart, Frank M Sacks, Michel P Hermans, et al.
The Lancet. Diabetes & Endocrinology|October 5, 2019
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statementRobert A Hegele, Jan Borén, Henry N Ginsberg, et al.
European Heart Journal|March 27, 2018
New prospects for PCSK9 inhibition?Ulf Landmesser, M John Chapman, Jane K Stock, et al.
European Heart Journal|May 2, 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Frederick J Raal, Robert A Hegele, et al.
Atherosclerosis|May 15, 2023
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis SocietyFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Pageof 18